Search Results - "Coelho, Ana L."

  • Showing 1 - 20 results of 20
Refine Results
  1. 1

    Quercetin Enhances Ligand-induced Apoptosis in Senescent Idiopathic Pulmonary Fibrosis Fibroblasts and Reduces Lung Fibrosis In Vivo by Hohmann, Miriam S, Habiel, David M, Coelho, Ana L, Verri, Jr, Waldiceu A, Hogaboam, Cory M

    “…Although cellular senescence may be a protective mechanism in modulating proliferative capacity, fibroblast senescence is now recognized as a key pathogenic…”
    Get full text
    Journal Article
  2. 2

    Targeting of TAM Receptors Ameliorates Fibrotic Mechanisms in Idiopathic Pulmonary Fibrosis by Espindola, Milena S, Habiel, David M, Narayanan, Rohan, Jones, Isabelle, Coelho, Ana L, Murray, Lynne A, Jiang, Dianhua, Noble, Paul W, Hogaboam, Cory M

    “…Idiopathic pulmonary fibrosis (IPF) is characterized by aberrant lung remodeling, which progressively abolishes lung function in an RTK (receptor tyrosine…”
    Get full text
    Journal Article
  3. 3

    Epigenetic regulation of the alternatively activated macrophage phenotype by Ishii, Makoto, Wen, Haitao, Corsa, Callie A.S., Liu, Tianju, Coelho, Ana L., Allen, Ronald M., Carson, William F., Cavassani, Karen A., Li, Xiangzhi, Lukacs, Nicholas W., Hogaboam, Cory M., Dou, Yali, Kunkel, Steven L.

    Published in Blood (08-10-2009)
    “…Alternatively activated (M2) macrophages play critical roles in diverse chronic diseases, including parasite infections, cancer, and allergic responses…”
    Get full text
    Journal Article
  4. 4

    Axl receptor blockade ameliorates pulmonary pathology resulting from primary viral infection and viral exacerbation of asthma by Shibata, Takehiko, Habiel, David M, Coelho, Ana L, Kunkel, Steven L, Lukacs, Nicholas W, Hogaboam, Cory M

    Published in The Journal of immunology (1950) (15-04-2014)
    “…Viruses use Tyro3, Axl, and Mertk (TAM) receptor tyrosine kinases to infect and modulate the immune properties of various cell types, which led us to…”
    Get full text
    Journal Article
  5. 5

    Effects of Mannosylerythritol-Lipids-B on Cutibacterium acnes ATCC 6919 by Coelho, Ana L. S., Laroque, Denise A., Feuser, Paulo E., de Andrade, Cristiano J., Carciofi, Bruno A. M., de Oliveira, Débora

    Published in Indian journal of microbiology (01-03-2024)
    “…Mannosylerythritol-lipids-B (MEL-B) are microbial-produced glycolipids with skincare properties, notably moisturizing, antimelanogenic, antimicrobial, and…”
    Get full text
    Journal Article
  6. 6

    Circulating Ang-2 mRNA expression levels: looking ahead to a new prognostic factor for NSCLC [corrected] by Coelho, Ana L, Araújo, António, Gomes, Mónica, Catarino, Raquel, Marques, Agostinho, Medeiros, Rui

    Published in PloS one (28-02-2014)
    “…Non-small cell lung cancer (NSCLC) is the most common cancer and the leading cause of death from cancer worldwide. Antiangiogenic strategies directed towards…”
    Get full text
    Journal Article
  7. 7

    The Chemokine CCL6 Promotes Innate Immunity via Immune Cell Activation and Recruitment by Coelho, Ana L, Schaller, Matthew A, Benjamim, Claudia F, Orlofsky, Amos Z, Hogaboam, Cory M, Kunkel, Steven L

    Published in Journal of Immunology (15-10-2007)
    “…Septic syndrome is a consequence of innate immune failure. Recent studies showed that the CC chemokine CCL6 enhanced antimicrobial immunity during experimental…”
    Get full text
    Journal Article
  8. 8

    Targeting ST2L Potentiates CpG-Mediated Therapeutic Effects in a Chronic Fungal Asthma Model by Ramaprakash, Hemanth, Shibata, Takehiko, Duffy, Karen E, Ismailoglu, Ugur B, Bredernitz, Rachel M, Moreira, Ana Paula, Coelho, Ana L, Das, Anuk M, Fursov, Natalie, Chupp, Geoffrey L, Hogaboam, Cory M

    Published in The American journal of pathology (01-07-2011)
    “…IL-33 and its soluble receptor and cell-associated receptor (ST2L) are all increased in clinical and experimental asthma. The present study addressed the…”
    Get full text
    Journal Article
  9. 9

    A systemic granulomatous response to Schistosoma mansoni eggs alters responsiveness of bone marrow-derived macrophages to Toll-like receptor agonists by Joshi, Amrita D., Raymond, Tracy, Coelho, Ana L., Kunkel, Steven L., Hogaboam, Cory M.

    Published in Journal of leukocyte biology (01-02-2008)
    “…Macrophages play a pivotal role in innate and acquired immune responses to Schistosoma mansoni. Classical (M1) or alternative (M2) activation states of these…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Modeling Idiopathic Pulmonary Fibrosis in Humanized Severe Combined Immunodeficient Mice by Habiel, David M., Espindola, Milena S., Coelho, Ana L., Hogaboam, Cory M.

    Published in The American journal of pathology (01-04-2018)
    “…Idiopathic pulmonary fibrosis (IPF) is a fibrotic lung disease of unknown etiopathogenesis with limited therapeutic options. IPF is characterized by an…”
    Get full text
    Journal Article
  12. 12

    19q13.11 microdeletion: Clinical features overlapping ectrodactyly ectodermal dysplasia‐clefting syndrome phenotype by Abe, Kikue Terada, Rizzo, Isabela M. P. O., Coelho, Ana L. V., Sakai, Nilo, Carvalho, Daniel R., Speck‐Martins, Carlos E.

    Published in Clinical case reports (01-07-2018)
    “…Key Clinical Message We report a patient who was followed for a long time under an ectrodactyly ectodermal dysplasia‐clefting (EEC) syndrome and was…”
    Get full text
    Journal Article
  13. 13

    Targeting MAP3K19 prevents human lung myofibroblast activation both in vitro and in a humanized SCID model of idiopathic pulmonary fibrosis by Jones, Isabelle C., Espindola, Milena S., Narayanan, Rohan, Coelho, Ana L., Habiel, David M., Boehme, Stefen A., Ly, Tai Wei, Bacon, Kevin B., Hogaboam, Cory M.

    Published in Scientific reports (24-12-2019)
    “…Idiopathic Pulmonary Fibrosis (IPF) is a disease with a devastating prognosis characterized by unrelenting lung scarring. Aberrant activation of lung…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Chemokines provide the sustained inflammatory bridge between innate and acquired immunity by Coelho, Ana L., Hogaboam, Cory M., Kunkel, Steven L.

    Published in Cytokine & growth factor reviews (01-12-2005)
    “…In this review we focus on the role of chemokines in discreet areas of innate immunity and demonstrate that chemokines are key participants to not only the…”
    Get full text
    Journal Article
  16. 16

    Phase II Study of Celecoxib with Cisplatin Plus Etoposide in Extensive-Stage Small Cell Lung Cancer by Araújo, António M.F., Mendez, Jose C., Coelho, Ana L., Sousa, Berta, Barata, Fernando, Figueiredo, Ana, Amaro, Teresina, Azevedo, Isabel, Soares, Marta

    Published in Cancer investigation (01-01-2009)
    “…We performed a phase II trial to test whether a cyclooxygenase (COX-2) inhibitor, celecoxib, added to standard first-line combination chemotherapy (CT) and as…”
    Get full text
    Journal Article
  17. 17
  18. 18

    CD4+ T cell cytokine production is influenced by jagged 1 by Schaller, Matthew A, Coelho, Ana L, Lukacs, Nicholas W, Kunkel, Steven L

    Published in The FASEB journal (01-04-2008)
    “…Notch is a promiscuous system consisting of four receptors and five ligands that is important for providing signals to direct cell differentiation in…”
    Get full text
    Journal Article
  19. 19

    Topotecan in second-line treatment of small-cell lung cancer--how it works in our daily clinical practice? by Faria, Ana Luísa Lourenço Moreira, Bravo, Emilio Macias, Rocha, Marta Alexandra Silva Soares, Rocha, Isabel Maria Azevedo, Coelho, Ana Luísa Pequeno, Araújo, António Manuel Ferreira

    Published in Current drug safety (01-04-2010)
    “…Lung cancer is one of the most commonly diagnosed malignancies and it causes more than 1 million deaths each year worldwide. Small-cell lung cancer (SCLC)…”
    Get more information
    Journal Article
  20. 20